Does Choice of Combination Antiretroviral Therapy (cART) Alter Changes in Cerebral Function Testing after 48 Weeks in Treatment‐Naive, HIV‐1–Infected Individuals Commencing cART? A Randomized, Controlled Study | Zendy

Alan Winston | Zendy; Chris Duncombe | Zendy; Patrick CK Li | Zendy; M. John Gill | Zendy; Stephen J. Kerr | Zendy; Rebekah Puls | Zendy; Kathy Petoumenos | Zendy; Simon D. TaylorRobinson | Zendy; Sean Emery | Zendy; David A. Cooper | Zendy

Open Access

Does Choice of Combination Antiretroviral Therapy (cART) Alter Changes in Cerebral Function Testing after 48 Weeks in Treatment‐Naive, HIV‐1–Infected Individuals Commencing cART? A Randomized, Controlled Study

Author(s) -

Alan Winston,

Chris Duncombe,

Patrick CK Li,

M. John Gill,

Stephen J. Kerr,

Rebekah Puls,

Kathy Petoumenos,

Simon D. TaylorRobinson,

Sean Emery,

David A. Cooper

Publication year - 2010

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/650743

Subject(s) - medicine , efavirenz , cart , ritonavir , neurocognitive , lopinavir , emtricitabine , gastroenterology , viral load , antiretroviral therapy , human immunodeficiency virus (hiv) , immunology , psychiatry , mechanical engineering , cognition , engineering

Neurocognitive impairment remains prevalent, despite combination antiretroviral therapy (cART). Differences between changes in cerebral function and alternative cARTs have not been prospectively assessed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research